SOCS1 Mutation Subtypes Predict Divergent Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Suppressor of cytokine signaling 1 (SOCS1) is frequently mutated in primary mediastinal and diffuse large B-cell lymphomas (DLBCL). Currently, the prognostic relevance of these mutations in DLBCL is unknown. To evaluate the value of the SOCS1 mutation status as a prognostic biomarker in DLBCL patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Schif, Birgit, Lennerz, Jochen K., Kohler, Christian W., Bentink, Stefan, Kreuz, Markus, Melzner, Ingo, Ritz, Olga, Trümper, Lorenz, Loeffler, Markus, Spang, Rainer, Möller, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702206/
https://www.ncbi.nlm.nih.gov/pubmed/23296022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702206/
https://www.ncbi.nlm.nih.gov/pubmed/23296022

Ejemplares similares